Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boulder/denver blog main
detroit blog main
indiana blog main
national
3
×
national blog main
national top stories
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
seattle blog main
texas blog main
texas top stories
wisconsin blog main
biogen
biotech
boston top stories
boulder/denver top stories
cancer
crispr
deals
detroit top stories
funding
gene therapy
indiana top stories
life sciences
medicare
merck
new york top stories
novartis
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle top stories
startups
venture capital
wisconsin top stories
abbvie
adalimumab (humira)
What
talk
3
×
bio
roundup
approval
becker
billions
biogen’s
biopharmaceutical
business
comes
companies
company
control
convo
developing
dollars
drug
earlier
eaton
effect
execs
external
factors
failures
founders
gene
healthcare
immigration
impact
innovation
investors
leaders
life
littered
michael
millions
moves
nash
new
news
Language
Current search:
talk
×
national
×
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
